متابعة
Hasanain Odhar
Hasanain Odhar
Al-Zahrawi University College
بريد إلكتروني تم التحقق منه على g.alzahu.edu.iq - الصفحة الرئيسية
عنوان
عدد مرات الاقتباسات
عدد مرات الاقتباسات
السنة
Molecular docking and dynamics simulation of FDA approved drugs with the main protease from 2019 novel coronavirus
HA Odhar, SW Ahjel, AAMA Albeer, AF Hashim, AM Rayshan, SS Humadi
Bioinformation 16 (3), 236, 2020
912020
Molecular docking enabled updated screening of the matrix protein VP40 from Ebola virus with millions of compounds in the MCULE database for potential inhibitors
HA Odhar, AM Rayshan, SW Ahjel, AA Hashim, AAMA Albeer
Bioinformation 15 (9), 627, 2019
262019
Computational Repurposing of FDA Approved Drugs Against Monkeypox Virus Cysteine Proteinase: A Molecular Docking and Dynamics Simulation Study.
HA Odhar
OSF Preprints, 2022
92022
Computational screening of FDA approved drugs from ZINC database for potential inhibitors of Zika Virus NS2B/NS3 protease: a molecular docking and dynamics simulation study
HA Odhar, SW Ahjel, ZA Odhar
Journal of Pharmaceutical Research International 33 (39B), 308-319, 2021
92021
Molecular docking and dynamics simulation analysis of nucleoprotein from the Crimea-Congo hemorrhagic fever virus strain Baghdad-12 with FDA approved drugs
AF Hashim, HA Odhar, SW Ahjel
Bioinformation 18 (5), 442, 2022
62022
Virtual Screening of FDA Approved Drugs Library to Identify a Potential Inhibitor against NS2B-NS3 Protease of Yellow Fever Virus
HA Odhar, SW Ahjel, A Albeer, AF Hashim, SS Humadi
J Pharm Res Int 33 (51B), 177-186, 2021
62021
Towards the design of epitope candidates for Coronavirus 2
HA Odhar, SW Ahjel, SS Humadi
Bioinformation 16 (5), 375, 2020
62020
Molecular docking analysis and dynamics simulation of salbutamol with the monoamine oxidase B (MAO-B) enzyme
HA Odhar, AF Hashim, SS Humad
Bioinformation 18 (3), 304, 2022
52022
Molecular docking and dynamics simulation of a screening library from life chemicals database for potential protein-protein interactions (PPIs) inhibitors against SARS-CoV-2 …
HA Odhar, SW Ahjel, AF Hashim, AM Rayshan
Journal of Pharmaceutical Research International 33 (28), 74-84, 2021
52021
Exploration of potential link between prevalence of irritable bowel syndrome and seropositivity for Helicobacter pylori
HA Odhar, AF Hashim, DH Obaid, RS Majeed, OA Habeeb, ...
Indian Journal of Public Health 10 (10), 2915, 2019
52019
Molecular docking and dynamics simulation analysis of the human FXIIa with compounds from the Mcule database
HA Odhar, AF Hashim, SW Ahjel, SS Humadi
Bioinformation 19 (2), 160, 2023
22023
Design and construction of multi epitope-peptide vaccine candidate for rabies virus
HA Odhar, AF Hashim, SS Humadi, SW Ahjel
Bioinformation 19 (2), 167, 2023
22023
Towards the design of multiepitope-based peptide vaccine candidate against SARS-CoV-2
HA Odhar, SW Ahjel, SS Humadi
BioRxiv, 2020.07. 07.186122, 2020
22020
A case of primary endometriosis associated with an umbilical hernia
ZA Odhar, MR Muhi, HA Odhar, Z Odhar, M Muhi
Cureus 14 (8), 2022
12022
Potential Trends for COVID-19 Fighting: An Immuno-informatics Overview
HA Odhar, SW Ahjel
OSF Preprints, 2020
12020
Clarifying the Relationship of Serum Levels of Iron and Copper with Type 2 Diabetes Mellitus
MA Hasan, SW Ahjel, HA Odhar, RM Hussein, MRA Alhaideri
Indian Journal of Forensic Medicine & Toxicology 13 (4), 888, 2019
12019
Identification of novel scaffolds for Monoamine oxidase B inhibitors
H Odhar
Kent State University, 2014
12014
Molecular docking, dynamics and in vitro analysis of multi-target inhibitors for Clostridioides difficile
NC Golchha, HA Odhar, A Nighojkar, S Nighojkar
Bioinformation 20 (1), 39, 2024
2024
VIRTUAL SCREENING OF FDA-APPROVED DRUGS BY MOLECULAR DOCKING AND DYNAMICS SIMULATION TO RECOGNIZE POTENTIAL INHIBITORS AGAINST MYCOBACTERIUM TUBERCULOSIS ENOYL-ACYL CARRIER …
HA ODHAR, AF HASHIM, SW AHJEL, SS HUMADI
Int J App Pharm 16 (1), 261-266, 2024
2024
LIGAND-BASED VIRTUAL SCREENING OF FDA-APPROVED DRUGS TO IDENTIFY NEW INHIBITORS AGAINST LACTATE DEHYDROGENASE ENZYME OF MALARIA PARASITES
HA ODHAR, AF HASHIM, SS HUMADI, SW AHJEL
Int J App Pharm 16 (1), 255-260, 2024
2024
يتعذر على النظام إجراء العملية في الوقت الحالي. عاود المحاولة لاحقًا.
مقالات 1–20